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Respiratory pressure responses to cervical magnetic stimulation are important measurements 24 
in monitoring the mechanical function of the respiratory muscles. Pressures can be measured 25 
using balloon catheters or a catheter containing integrated micro-transducers. However, no 26 
research has provided a comprehensive analysis of their pressure measurement 27 
characteristics. Accordingly, the aim of this study was to provide a comparative analysis of 28 
these characteristics in two separate experiments: (1) in vitro with a reference pressure 29 
transducer following a controlled pressurization; and (2) in vivo following cervical magnetic 30 
stimulations. In vitro the micro-transducer catheter recorded pressure amplitudes and areas 31 
which were in closer agreement to the reference pressure transducer than the balloon catheter. 32 
In vivo there was a main effect for stimulation power and catheter for esophageal (Pes), gastric 33 
(Pga) and transdiaphragmatic (Pdi) pressure amplitudes (P < 0.001) with the micro-transducer 34 
catheter recording larger pressure amplitudes. There was a main effect of stimulation power 35 
(P < 0.001) and no main effect of catheter for esophageal (P = 0.481), gastric (P = 0.923) and 36 
transdiaphragmatic (P = 0.964) pressure areas. At 100% stimulator power agreement between 37 
catheters for Pdi amplitude (bias = 6.9 cmH2O and LOA -0.61 to 14.27 cmH2O) and pressure 38 
areas (bias = -0.05 cmH2O·s and LOA -1.22 to 1.11 cmH2O·s) were assessed. At 100% 39 
stimulator power, and compared to the balloon catheters, the micro-transducer catheter 40 
displayed a shorter 10-90% rise time, contraction time, latency and half-relaxation time, 41 
alongside greater maximal rates of change in pressure for esophageal, gastric and 42 
transdiaphragmatic pressure amplitudes (P < 0.05). These results suggest that caution is 43 
warranted if comparing pressure amplitude results utilizing different catheter systems, or if 44 
micro-transducers are used in clinical settings while applying balloon catheter derived 45 
normative values. However, pressure areas could be used as an alternative point of 46 
comparison between catheter systems. 47 
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NEW & NOTEWORTHY 50 
Micro-transducer and balloon catheter pressure measurements were compared under in vivo 51 
and in vitro conditions. The results showed that: (1) in vivo the micro-transducer catheter 52 
demonstrated shorter response times, greater rates of change in pressure and greater pressure 53 
amplitudes; (2) there were no differences in pressure areas between catheters in vivo or in 54 
vitro. These results demonstrate that micro-transducer and balloon catheters are not directly 55 
comparable when measuring pressure amplitudes in response to cervical magnetic 56 
stimulation, however pressure area could be used as an alternative point of comparison.     57 




Respiratory pressure responses to nerve stimulation are important measurements in 59 
monitoring the mechanical function of the respiratory muscles (Macklem, 2004, Romer and 60 
Polkey, 2008, Laveneziana et al., 2019, American Thoracic Society, 2003). As measurements 61 
of pleural and abdominal pressures are invasive, they are typically estimated using surrogate 62 
measures of esophageal (Pes) and gastric (Pga) pressures, respectively (Benditt, 2005, 63 
Laveneziana et al., 2019). Traditionally, these measurements are collected with balloon 64 
catheters (Milic-Emili et al., 1964, Baydur et al., 1982), but variations in catheter design, 65 
manual inflation of the balloon with either air or fluid, and catheter placement can lead to 66 
under or overestimation of pressure (Milic-Emili et al., 1964, Petit and Milic-Emili, 1958, 67 
Mead et al., 1955, Mojoli et al., 2015, Walterspacher et al., 2014).  68 
There are a variety of commercially available balloon catheter designs and each requires a 69 
different quantity of air for optimum performance, and under and over inflation of balloons 70 
can produce invalid estimations of pressure (Milic-Emili et al., 1964, Mojoli et al., 2015, 71 
Walterspacher et al., 2014). The perimeter and length of a balloon, along with its elastance, 72 
can also affect measurement accuracy (Petit and Milic-Emili, 1958, Mead et al., 1955, Mojoli 73 
et al., 2015). Pressures are also affected by the location of the balloon within the body and are 74 
therefore dependent on placement technique (Petit and Milic-Emili, 1958, Mead and 75 
Whittenberger, 1953). The proximal end of a balloon catheter is attached via plastic tubing to 76 
a pressure transducer located outside the body. Increasing the tubing length between the 77 
balloon and the transducer leads to reduced flow within the tubing (i.e., Poiseuille’s Law), 78 
which may compromise dynamic response characteristics in balloon catheter systems (Cross 79 
et al., 2016, Mead et al., 1955, Mojoli et al., 2015, Walterspacher et al., 2014). Furthermore, 80 
balloon elasticity may change over time due to repeated sterilization and re-use. These issues 81 
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may explain the limited uptake of balloon catheters in clinical settings (Mauri et al., 2016, 82 
Mojoli et al., 2015) despite their many medical applications (Akoumianaki et al., 2014, Mauri 83 
et al., 2016).  84 
The primary alternative to a balloon catheter is a catheter containing one or two integrated 85 
micro-transducers (Beardsmore et al., 1982, Gilbert et al., 1979, Evans et al., 1993). Since 86 
micro-transducer catheters do not utilize a balloon or require tubing to connect to an external 87 
transducer, they may overcome some of the limitations associated with traditional balloon 88 
catheters. However, despite these benefits, micro-transducer measurements of Pes are more 89 
susceptible to mucus adhesion and contact with the esophageal wall, which reduces the 90 
surface area and therefore the spread of Van der Waals forces (Peters et al., 1998). 91 
Unpredictable shifts in baseline Pes have also been reported and are partly attributed to the 92 
micro-transducers susceptibility to differences in pressures across the esophagus (Beardsmore 93 
et al., 1982), to regional artefacts (Panizza and Finucane, 1992) and baseline pressure drift in 94 
the device over time (1999). Recently, Augusto et al.  reported no clinically relevant drift 95 
following 1 h of submersion with a Gaeltech micro-transducer catheter. Micro-transducer 96 
measurements of Pga may be also affected by immersion in gastric fluids (Stell et al., 1999).  97 
Despite the potential benefits of the micro-transducer catheter, only a limited number of 98 
studies have compared their pressure responses with those of a balloon catheter, and the 99 
results remain controversial. Poor agreement has been reported for absolute Pes and Pga (Stell 100 
et al., 1999, Peters et al., 1998, Beardsmore et al., 1982, Augusto et al., 2017), whereas both 101 
good (Stell et al., 1999, Peters et al., 1998) and poor (Augusto et al., 2017, Beardsmore et al., 102 
1982) agreement has been reported for relative Pes and Pga (i.e., amplitude relative to 103 
baseline). Moreover, ambiguous evidence is provided by other studies that describe micro-104 
transducer and balloon catheters as “measuring pressures similarly” (Evans et al., 1993) and 105 
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as “providing comparable measurements of absolute Pes and Pga” (Gilbert et al., 1979). As 106 
such, it is not clear how comparable the two devices are and which device measures pressure 107 
more accurately. 108 
Analysis of magnetic or electrical cervical stimulation is important for the comprehensive 109 
assessment of the mechanical and neural properties of the respiratory muscles (Laghi et al., 110 
1996, Similowski et al., 1989, Similowski et al., 1996, Similowski et al., 1998, Taylor et al., 111 
2006, Similowski et al., 1991, Man et al., 2004). Thus, understanding the accuracy and 112 
comparability of the two devices in measuring these responses is important for the correct 113 
interpretation of these measurements. While previous studies have evaluated the differences 114 
in pressures between balloon and micro-transducer catheters (Augusto et al., 2017, Stell et al., 115 
1999, Panizza and Finucane, 1992, Beardsmore et al., 1982), none have provided a 116 
comprehensive analysis of their pressure measurement characteristics following electric or 117 
magnetic stimulations. Accordingly, this study provides a thorough assessment of a range of 118 
characteristics for Pes, Pga and transdiaphragmatic pressure (Pdi) in response to controlled 119 
pressurizations in vitro and to cervical magnetic stimulation in vivo.    120 




Experimental overview 122 
This study comprised two separate experiments to evaluate the pressure measurement 123 
characteristics of a micro-transducer catheter and balloon catheters. Experiment 1 evaluated, 124 
in vitro, the pressure amplitudes and areas of both catheter types following a controlled 125 
pressurization, with their responses compared to a reference pressure. Experiment 1 was also 126 
used to identify whether differences in catheter responses are present after removal of 127 
physiological factors such as mucus adhesion and immersion in gastric fluids. Experiment 2 128 
evaluated, in vivo, the characteristics of both catheter types in human participants following 129 
cervical magnetic stimulation. The study was approved by the University of Southern 130 
Queensland’s Ethics Committee and all procedures conformed to the standards set by the 131 
Declaration of Helsinki. 132 
 133 
Experiment 1 – in vitro 134 
Protocols 135 
The micro-transducer catheter and a single balloon catheter were positioned in a sealed 136 
pressurized polyvinylchloride chamber (length = 25 cm; radius = 1 cm) alongside a reference 137 
pressure transducer (piezo-resistive pressure transmitter MRB20; Bestech, Brisbane, 138 
Australia). The reference pressure was the standard against which pressures recorded by the 139 
micro-transducer and balloon catheters were compared (measurement range = 500 cmH2O; 140 
frequency response = 1 kHz). The reference pressure transducer was calibrated at room 141 
temperature using a water manometer with a 1 m water column. The balloon catheter was 142 
inflated with 1 mL of air from a glass syringe, and both catheter types were then calibrated 143 
within the chamber at 100 cmH2O as measured by the reference pressure transducer. The 144 
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catheters were then exposed to chamber pressures of 25, 50, 75 and 100 cmH2O (n = 100 for 145 
each) with a constant pressurization time of 0.2 s. For experiment 1, the same micro-146 
transducer catheter and a single balloon catheter were used, and all measurements were taken 147 
on the same day.  148 
The micro-transducer catheter and balloon catheter were secured on a mounting board with 149 
the micro-transducers aligned to the centers of the balloons. This assembly and the reference 150 
pressure transducer were placed inside the airtight chamber which was pressurized using a 151 
gas supply (79% N2, 16% O2 and 5% CO2; BOC, North Ryde, Australia). The cylinder was 152 
fitted with a Type 10 valve (flow coefficient = 0.4; BOC, North Ryde, Australia) leading to a 153 
regulator (6000 Argon Gas Regulator; BOC) with an upstream pressure of 2900 PSI. 154 
Maximum chamber pressures were adjusted via the regulator to obtain maximum pressure at 155 
the end of a 0.2 s pressurization time. Pressurization was automated by using the Powerlab 156 
16/35 to control a 2-way normally open isolation valve (NR3-2-12; VFV, Mitcham, 157 
Australia). When the gas flow was switched off by the isolation valve, depressurization was 158 
complete within 150 – 250 ms.  159 
 160 
Experiment 2 – in vivo 161 
Participants  162 
Healthy young male (n = 4) and female (n = 4) participants (age = 29 ± 3 years; height = 173 163 
± 11 cm; body mass = 84.7 ± 9.6 kg) with normal pulmonary function (forced vital capacity = 164 
98 ± 9% predicted; forced expiratory volume in 1 s = 95 ± 9% predicted) provided written 165 
informed consent to participate in this study. Exclusion criteria included current cigarette 166 
smokers, a history or current symptoms of cardiopulmonary disease, and a body mass index 167 
of <18.5 or >30 kg/m2.  168 
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Experimental design 169 
Each participant visited the laboratory on two occasions, at a similar time of day, separated 170 
by a minimum of 24 h and a maximum of 7 days. Before each visit, participants abstained 171 
from food for 4 h, caffeine for 12 h, and exercise for 48 h. During visit 1, anthropometric 172 
measures and pulmonary function were assessed using a spirometer (Vmax® Encore PFT 173 
system; Vyaire Medical, Chicago, USA) according to published guidelines (Miller et al., 174 
2005). Participants were instrumented with a micro-transducer catheter to evaluate Pes, Pga 175 
and Pdi responses to cervical magnetic stimulation. The micro-transducer catheter was then 176 
removed, and participants were instrumented with esophageal and gastric balloon catheters 177 
and pressure responses to cervical magnetic stimulation were re-evaluated. During visit 2, the 178 
order of catheter placement was reversed. The duration between removal of catheter(s) and 179 
instrumentation of the next catheter(s) was ~10 min. 180 
 181 
Respiratory pressure catheters 182 
The micro-transducer catheter (Gaeltech, Dunvegan, UK) housed two pressure transducers 183 
(~5 × 2 mm), separated by 22.8 cm, which were constructed using half bridge thin film 184 
resistive strain gauge sensors coated with a silicone elastomer with frequency responses of 185 
10-20 kHz. The catheter comprised a 100 cm silicon shaft (2.7 mm diameter) that also 186 
contained nine silver electrodes spaced 1 mm apart (electromyography data not reported here) 187 
and the pressure transducers were positioned proximally and distally to the electrodes. Prior 188 
to instrumentation in vivo the catheter was soaked for 1 h as per manufacturer’s instructions 189 
to reduce baseline drift. The micro-transducer catheter was then placed inside a small section 190 
of airtight plastic tubing and calibrated by injecting or withdrawing air, via a 3-way open 191 
valve connected to a glass syringe and a handheld respiratory pressure meter (Micro RPM; 192 
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Vyaire Medical, Chicago, USA). Pes was calibrated to -100 cmH2O and Pga to +100 cmH2O. 193 
The external transducers of the balloon catheters were connected, via a 3-way open valve, 194 
directly to the respiratory pressure meter and glass syringe. These transducers were calibrated 195 
between -27 cmH2O and +100 cmH2O by injecting and withdrawing air. The two balloon 196 
catheters consisted of a thin walled (~0.6 mm) polytetrafluoroethylene balloon (9.5 cm in 197 
length) sealed over an 86 cm long polyethylene catheter (Adult esophageal balloon catheter; 198 
Cooper Surgical, Trumball, USA). These were connected to external pressure transducers 199 
with maximum frequency responses of 300 Hz and a pressure range of -27 to 407 cmH2O 200 
(SP844 Pressure Transducer; MEMSCAP, San Jose, USA). Pdi was calculated automatically 201 
using LabChart Pro software (AD Instruments, Bella Vista, Australia) by subtracting Pes from 202 
Pga.  203 
 204 
Catheter placement 205 
Catheter placement was preceded by intranasal administration of 1 mL of anesthetic lidocaine 206 
hydrochloride gel (Instillagel; MD Solutions Australasia, Williamstown North, Australia). 207 
The positioning of the micro-transducer catheter was achieved as previously described (Luo 208 
et al., 2001). The catheter was passed peri-nasally into the stomach until a positive deflection 209 
in Pga and a negative deflection in Pes were observed during repeated sniffs. The catheter was 210 
then repositioned based on the strength of the crural diaphragm EMG simultaneously from 211 
different pairs of electrodes and was then secured in place. An occlusion test was then 212 
performed to confirm the catheters location in the esophagus (Baydur et al., 1982). As 213 
esophageal diaphragm EMG is sensitive to differences in positioning (Luo et al., 2000), the 214 
micro-transducer was positioned first to ensure the collection of quality EMG data. 215 
Subsequently, the deflated balloon catheters were inserted through the same nostril used for 216 
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the micro-transducer catheter. The centers of the respective balloons were positioned at the 217 
same distance from the nares as the micro-transducers. The esophageal and gastric balloons 218 
were inflated with 1 and 2 mL of air, respectively. Pes and Pga deflections were then observed 219 
during repeated sniffs to check positioning, before being further assessed by an occlusion 220 
test. If required, the location of the balloon catheters was then altered to ensure accurate Pes 221 
and Pga measurements. The position of the catheters, relative to the nares, was identical 222 
during visits 1 and 2. This process allowed for the optimization of Pes, Pga and EMG signals.  223 
 224 
Cervical magnetic stimulation  225 
After an initial 20 min seated rest period to minimize post activation potentiation (Wragg et 226 
al., 1994), cervical magnetic stimulation was performed using a 90 mm circular coil attached 227 
to a magnetic stimulator (2002; Magstim, Whitland, United Kingdom) . Participants wore a 228 
nose-clip and were seated in a chair with their neck flexed. Stimulations were performed with 229 
the glottis closed at functional residual capacity, which was inferred from visual feedback of 230 
Pes (i.e., an elevated plateau at the end of a tidal breath). The optimal stimulation site was 231 
determined by performing multiple stimulations at submaximal intensity (50% stimulator 232 
power) along C5-C7 until the maximal Pdi, and thus the optimal stimulation site, was 233 
determined. This site was marked with indelible ink and used for all subsequent stimulations. 234 
Pes, Pga and Pdi amplitudes were not different between visits, indicating that all stimulations 235 
were delivered with the same thoracoabdominal configuration. Pressure systems were 236 
compared at intensities of 50, 60, 70, 80, 85, 90, 95, and 100% of stimulator power output, 237 
with a minimum of three stimulations recorded at each intensity. Additional stimulations 238 
were performed when Pes or Pga values at end expiration were not at a stable baseline value. A 239 
30 s pause was maintained between stimulations to prevent twitch-on-twitch potentiation 240 
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(Guenette et al., 2010, Polkey et al., 1995, Welch et al., 2017, Welch et al., 2018, Taylor and 241 
Romer, 2009).  242 
 243 
Pressure capture and response analyses 244 
Pressures were amplified with a Quad Bridge Amplifier (FE224; ADInstruments, Bella Vista, 245 
Australia) and all data were sampled continuously at 10 kHz using a Powerlab 16/35 and 246 
recorded using LabChart v8.1.2 software (ADInstruments, Bella Vista, Australia). Low pass 247 
filters were set at 10 Hz for the balloon catheter pressure transducers and 1 kHz for the 248 
micro-transducer catheter and the reference pressure transducer. In experiment 1 pressure 249 
amplitudes and areas were analysed. In experiment 2 pressure amplitude, percentage of 250 
maximum amplitude, latency, contraction time, pressure area, 10-90% rise time, half-251 
relaxation time, time constant, maximal rate of pressure development (MRPD), maximal 252 
relaxation rate (MRR) and time to peak pressure using customized macroinstructions 253 
(LabChart v8.1.2 software; ADInstruments) (Figure 1).  254 
 255 
[Figure 1] 256 
 257 
Pressure amplitude was calculated as the difference between baseline and peak pressure. 258 
Response onset was defined as the point at which pressure deviated 5% from baseline. Offset 259 
was defined as the point at which pressure returned to ± 5% of baseline. Latency was defined 260 
as the time difference between magnetic stimulation and response onset (Experiment 2) or the 261 
time difference between valve opening and response onset (Experiment 1). Contraction time 262 
was defined as the duration between response onset and 100% of peak pressure. Pressure area 263 
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was calculated using integration between response onset and offset. The 10-90% rise time 264 
was defined as the elapsed time between 10% and 90% of peak pressure. Half-relaxation time 265 
was defined as the elapsed time between 100% and 50% of peak pressure. The time constant 266 
was calculated between 60% and 10% of pressure amplitude. Time to peak pressure was 267 
defined as latency plus contraction time. MRPD and MRR were calculated based on 268 
equations [1] and [2] from previous work (Similowski et al., 1991).  269 
𝑀𝑅𝑃𝐷 = max |
𝑑𝑃
𝑑𝑡
| ÷ 𝐴 
 
𝑀𝑅𝑅 = max |
𝑑𝑃
𝑑𝑡






Where dP/dt is the rate of change of pressure and A is amplitude of the pressure response. 271 
 272 
Statistical analyses 273 
Statistical analyses were performed using SPSS for Windows (IBM, Chicago, USA). An 274 
initial power calculation was performed on the basis of the Pdi amplitudes for the balloon 275 
catheters and micro-transducer catheter following cervical magnetic stimulation at 100% of 276 
stimulator power output. Power analysis indicated that a sample size of 8 would be required 277 
to detect differences in Pdi amplitudes between catheters (alpha = 0.05 and power = 0.8). 278 
Normality was assessed using a Shapiro-Wilk test. Supramaximality was determined by 279 
identifying a plateau in mean twitch Pdi at increasing stimulation power using a one-way 280 
repeated measures ANOVA followed by pairwise comparisons (Guenette et al., 2010).  281 
Between-visit and between-catheter pressure measurement characteristics at 100% of 282 
maximum stimulator output in response to cervical magnetic stimulation were analyzed using 283 
a paired sample t-tests or Wilcoxon signed ranks test for parametric and non-parametric data, 284 
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respectively. Between-catheter differences for pressure amplitudes and areas at increasing 285 
stimulation intensities were analyzed using a two-way repeated measures ANOVA to 286 
determine the effects of stimulation ‘intensity’ (50, 60, 70, 80, 85, 90, 95 and 100% of 287 
maximum stimulation output) and ‘catheter’ (micro-transducer vs. balloon catheter). 288 
Significant intensity × catheter interaction effects were followed by planned pairwise 289 
comparisons between catheters using the Bonferroni method.  290 
The agreement, relationship and reliability characteristics for pressure amplitudes and areas 291 
between the micro-transducer catheter and balloon catheters were determined from data 292 
collected from all chamber pressures (Experiment 1 – in vitro) or stimulation intensities 293 
(Experiment 2 – in vivo). Bland-Altman analysis was used to evaluate the agreement between 294 
balloon and micro-transducer catheter pressure measurements (Giavarina, 2015). Bias was 295 
defined as the micro-transducer catheter measurement minus the balloon catheter 296 
measurement (experiment 1, in vivo), or as the reference transducer measurement minus the 297 
catheter measurement (experiment 2, in vitro). Limits of agreement (LOA) were calculated as 298 
the mean difference (bias) ± 1.96 SD. Pearson’s product moment correlation coefficient was 299 
used to examine the relationship between catheters. Within-day reliability was assessed using 300 
coefficients of variation (CV) with the method error of the measurement (i.e., standard 301 
deviation divided by the mean). Between-day reliability was assessed by using CV and the 302 
intraclass correlation coefficient (ICC(2,k)). Statistical significance was set at P < 0.05. 303 
Results are presented as means ± SD unless stated otherwise.   304 




Experiment 1 – in vitro 306 
Ensemble averaged pressure responses to increasing chamber pressurizations for the micro-307 
transducer catheter, balloon catheter and reference transducer are shown in Figure 2. Table 1 308 
shows the measurement characteristics and agreement for pressure amplitudes and areas 309 
between the micro-transducer catheter and balloon catheter and at increasing chamber 310 
pressures of 25, 50, 75 and 100 cmH2O with a constant pressurization time of 0.2 s. Pressure 311 
amplitudes were higher for the micro-transducer catheter compared to the balloon catheter at 312 
all chamber pressures. Pressure areas for the micro-transducer catheter were slightly higher 313 
than for the balloon catheter, with some exceeding that of the reference pressure at chamber 314 
pressures of 25 and 50 cmH2O, respectively (Table 1). Despite this, micro-transducer catheter 315 
pressure amplitudes and areas were closer to reference values than the balloon catheters with 316 
the largest differences between the catheters occurring at the lowest chamber pressure (25 317 
cmH2O; Table 1).  318 
 319 
[Figure 2] [Table 1] 320 
 321 
For pressure amplitudes and areas, agreement with the reference pressure transducer was 322 
closer (reflected by a lower bias) for the micro-transducer catheter than the balloon catheter 323 
(Table 1). Significant correlations between the catheters for pressure amplitude were present 324 
at chamber pressures of 25 (r = 0.84), 50 (r = 0.78), 75 (r = 0.91) and 100 (r = 0.91) cmH2O 325 
(P < 0.001). Similarly, correlations between the catheters for pressure area were also present 326 
at chamber pressures of 25 (r = 0.77), 50 (r = 0.79), 75 (r = 0.84) and 100 (r = 0.90) cmH2O 327 
(P < 0.001). Within-day reliability was high for both micro-transducer and balloon catheters 328 
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for pressure amplitudes (micro-transducer vs. balloon catheters): 0.25 (CI 0.22 to 0.27) vs. 329 
0.22 (CI 0.20 to 0.24 %) and areas 0.29 (CI 0.27 to 0.31) vs. 0.25 (CI 0.24 to 0.27) %.  330 
 331 
Experiment 2 – in vivo 332 
Representative pressure responses to cervical magnetic stimulation at 100% of stimulator 333 
power output for the balloon catheters and micro-transducer catheter are shown in Figure 3. 334 
There were no between-visit differences for all pressure measurement characteristics for the 335 
micro-transducer (P = 0.055) and balloon catheters (P = 0.314). Therefore, data from visits 1 336 
and 2 were pooled. Supramaximality was achieved from 80% (P > 0.055) and 90% (P > 337 
0.105) stimulator power output for the balloon and micro-transducer catheters. 338 
 339 
[Figure 3] 340 
 341 
Table 2 shows the Pes, Pga and Pdi pressure measurement characteristics for the balloon 342 
catheters and micro-transducer catheter following cervical magnetic stimulation at 100% of 343 
stimulator power output. Compared to the balloon catheters, the micro-transducer catheter 344 
displayed shorter 10-90% rise times, contraction times, latencies and half-relaxation times, 345 
and greater maximal rates of changes in pressure (MRPD and MRR) and pressure amplitudes 346 
(P < 0.05). When pressure amplitudes were normalized to percentage of maximum, there was 347 
no difference between catheters, nor were there any differences between catheters for 348 
pressure area. Pga and, subsequently, Pdi were higher (P < 0.05) at end-expiration for the 349 
micro-transducer catheter than the balloon catheters. 350 
 351 
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[Table 2] 352 
 353 
Pes, Pga and Pdi amplitudes and areas from the micro-transducer and balloon catheters in 354 
response to increasing stimulation intensities are shown in Figure 4. Both catheters responded 355 
linearly to increasing stimulation intensities. For Pes, Pga and Pdi amplitude, there were main 356 
effects of stimulation intensity (P < 0.001) and catheter (P < 0.001). That is, pressure 357 
amplitudes increase with stimulation intensity and are higher for the micro-transducer 358 
catheter. No intensity × catheter interaction effects (P > 0.935) were observed. For Pes, Pga 359 
and Pdi pressure areas, there was a main effect of stimulation intensity (P < 0.001) with 360 
pressure area increasing with stimulation intensity. There were no main effects of catheter (P 361 
= 0.481) or stimulation intensity × catheter interaction effects (P > 0.995). 362 
 363 
[Figure 4] 364 
 365 
Bland-Altman plots for the agreement between the micro-transducer and balloon catheters for 366 
Pes, Pga and Pdi amplitudes and areas in response to cervical magnetic stimulation are shown 367 
in Figure 5. Pes, Pga and Pdi amplitudes had biases of 3.8 (LOA -0.55 to 8.26), 4.2 (LOA -6.64 368 
to 15.09) and 6.9 (LOA -0.61 to 14.27) cmH2O, respectively. Significant correlations 369 
between the catheters for Pes (r = 0.96), Pga (r = 0.77) and Pdi (r = 0.94) amplitudes were 370 
moderate to strong (P < 0.001). Pes, Pga and Pdi pressure areas had biases of -0.08 (LOA -0.70 371 
to 0.54), -0.03 (LOA -3.75 to 3.68) and -0.05 (LOA -1.22 to 1.11) cmH2O∙s, respectively. 372 
Significant ccorrelations between the catheters for Pes (r = 0.94), Pga (r = 0.84) and Pdi (r = 373 
0.91) were moderate to strong (P < 0.001).  374 
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[Figure 5] 375 
 376 
Within- and between-day reliability coefficients for Pes, Pga and Pdi amplitudes and areas in 377 
response to cervical magnetic stimulation at 100% of stimulator output for the micro-378 
transducer and balloon catheters are shown in Table 3. Within- and between-day reliability 379 
for Pes and Pdi amplitudes and areas were similar between the catheters. For the micro-380 
transducer compared to the balloon catheters, Pga amplitudes and areas had lower within-day 381 
reliability and higher between-day reliability.     382 
 383 
[Table 3] 384 
 385 




Main findings 387 
This study is the first to provide a comprehensive analysis of a range of balloon and micro-388 
transducer catheter pressure measurement characteristics in vitro with a reference pressure  389 
following controlled pressurizations (Experiment 1) and in vivo following cervical magnetic 390 
stimulation (Experiment 2). The main findings were: (1) in vitro the micro-transducer 391 
catheter showed closer agreement to the reference pressure amplitudes and areas than the 392 
balloon catheter; (2) in vivo the micro-transducer catheter recorded higher pressure 393 
amplitudes and similar pressure areas than the balloon catheters; and (3) in vivo the micro-394 
transducer catheter displayed shorter pressure response times and half-relaxation times, and 395 
greater maximal rates of changes in pressure than the balloon catheters. 396 
 397 
Pressure amplitudes 398 
In vivo the micro-transducer catheter had higher pressure amplitudes compared to the balloon 399 
catheters. While no Pes agreement data following cervical magnetic stimulation have 400 
previously been reported, the values here are similar to those reported during quiet breathing 401 
(bias = -3.6 cmH2O, LOA -14.3 to 7 cmH2O) and demonstrate better agreement than those 402 
reported during sniff maneuvers (bias = -50.6 cmH2O, LOA -60.6 to -40.6 cmH2O) (Augusto 403 
et al., 2017). The presence of differences in pressure measurement is also consistent with 404 
previous work (Augusto et al., 2017, Beardsmore et al., 1982, Peters et al., 1998, Stell et al., 405 
1999). The in vivo Pdi results presented here with a bias of 6.9 (LOA -0.61 to 14.27) cmH2O 406 
are higher than those previously reported by Stell et al.  with a bias of 2.1 (LOA -10.5 to 6.3) 407 
cmH2O. This difference is likely due to methodological and technical differences between the 408 
studies. For instance, Stell et al.  placed micro-transducer and balloon catheters 409 
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simultaneously into their participants, thus exposing them to identical physiological 410 
conditions (i.e., excluding some of the within-day variability potentially experienced during 411 
sequential catheter placements). The balloon catheters utilized by Stell et al.  were from a 412 
different manufacturer, with a longer catheter (+24 cm) and balloons (+0.5 cm) and a 413 
different filling volumes for Pes (0.5 mL). These differences respectively may affect the 414 
dynamic compliance, while differences in balloon filling volumes affect pressure 415 
measurements (Cross et al., 2016, Milic-Emili et al., 1964, Mojoli et al., 2015, Walterspacher 416 
et al., 2014). There are no published values of Pga available against which to compare our 417 
results.  418 
The in vitro results also demonstrated that the micro-transducer catheter recorded higher 419 
pressure amplitudes than the balloon catheter and the pressures obtained were closer to the 420 
reference pressure. The differences in pressure amplitude between the catheters are likely due 421 
to the faster dynamic responses of the micro-transducer catheter, allowing it to reach higher 422 
pressures more quickly than the balloon catheter, and thus more closely tracking rapid 423 
pressurization. In vivo, the within- and between-day reliability coefficients for Pes and Pdi 424 
amplitudes were similar between the catheters and to those reported previously for balloon 425 
catheters (Taylor and Romer, 2009, Wüthrich et al., 2015, Tiller et al., 2017). However, the 426 
within- and between-day reliability coefficients for Pga from the micro-transducer catheter 427 
were higher than those of the balloon catheter and slightly higher than those reported 428 
previously for balloon catheters (Tiller et al., 2017). The differences may be explained by the 429 
greater sensitivity of the micro-transducer catheter to pressure changes that occur readily 430 
within the stomach. The within-day repeatability of pressure amplitudes and areas in vitro 431 
was high for both catheters, which suggests that when physiological factors are excluded, 432 
there are no inherent differences in the reliability of balloon and micro-transducer catheters. 433 
 434 
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   435 
Pressure areas 436 
The most common measurement of respiratory muscle strength is pressure amplitude (i.e., 437 
twitch pressures), however pressure area is also indicative of muscular work output 438 
(Carámbula et al., 2019, Bazzucchi et al., 2011, Celichowski et al., 2000). Areas have been 439 
reported for twitch tension (Lepers et al., 2000, Lewis et al., 2017) and twitch peak torque 440 
(Lepers et al., 2002) following electrical quadricep stimulations, but to the best of our 441 
knowledge have not been reported for the diaphragm following cervical magnetic 442 
stimulation. The pressure area envelope is “triangular” and pressure amplitude determines the 443 
perpendicular height of the triangle from base to apex, while the pressure response and 444 
relaxation rates control the slopes up and down from the apex. Thus, changes in pressure area 445 
are reflective predominantly of pressure amplitude, while also being influenced by 446 
differences in response and relaxation rates.  447 
The micro-transducer catheter demonstrated higher pressure amplitudes and sharper 448 
waveforms. Conversely the balloon catheter displayed lower pressure amplitudes and blunter 449 
waveforms. Thus, despite the shape of the waveform recorded by the catheters being visibly 450 
different, the pressure areas are similar. This is evidenced in vitro by agreement values closer 451 
to zero and relative pressure area values that were closer to 100% for the micro-transducer 452 
catheter. In vivo this is shown by the lack of main effect of catheter on pressure area results. 453 
However, the CV values for the within- and between-day reliability indicates that pressure 454 
area measurements are less reliable than pressure amplitudes. Assessment of between-day 455 
reliability using ICC indicates a higher degree of variability in Pga and Pdi amplitudes and 456 
areas as these values had wide CI, with some incorporating negative lower limits. While this 457 
indicates that the measures are unreliable, there is no significant evidence of differences in 458 
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reliability between devices, or between pressure amplitudes and areas. Hence, these data 459 
indicate that pressure area could provide a measurement suitable for direct comparisons 460 
between micro-transducer and balloon catheters. 461 
Pressure responses, half-relaxation times, and rates of pressure change  462 
This is the first study to provide a comparative analysis of the pressure measurement 463 
characteristics of a micro-transducer and balloon catheters following cervical magnetic 464 
stimulations. In vivo, the Pes, Pga and Pdi responses of the micro-transducer catheter had 465 
shorter latencies, 10-90% rise times, time to peak pressure and a greater MRPD than the 466 
balloon catheter in response to cervical magnetic stimulation. Furthermore, as pressures 467 
returned to baseline, the micro-transducer catheter had shorter half-relaxation times and 468 
greater maximal relaxation rates. No differences were observed in the time constant for Pes, 469 
Pga or Pdi. The larger variability of time constant values observed in Pga (and thus Pdi) are due 470 
to the secondary peaks occurring in some gastric response curves. These alter the decay 471 
waveform from the standard exponential form, causing variability in the calculation of the 472 
time constant. Hence, caution is advised when collecting and analyzing time constant data. 473 
These response characteristic data show that the micro-transducer catheter demonstrated 474 
“faster” responses to changes in pressures than balloon catheters. This does not imply that it 475 
performs better than the balloon catheter in measuring pressures in vivo. However, their faster 476 
responses do produce different waveforms in response to cervical magnetic stimulation, with 477 
the micro-transducer catheter providing sharper and shorter response curves than the balloon 478 
catheters. The differences in catheter responses can be attributed to their unique designs, with 479 
the micro-transducer having a greater inherent capacity for fast responses. 480 
 481 
Methodological considerations 482 
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Experiment 1. Ideally any reference waveform used in in vitro respiratory testing should 483 
include waveforms with spectral content greater than 20 Hz. However, those presented in 484 
Experiment 1 were approximately 5 Hz and thus a deeper comparison of these data to assess 485 
the dynamic response characteristics of the catheters was not possible.    486 
 487 
Clinical implications  488 
Low Pdi amplitudes (i.e., twitch pressures) in response to un-potentiated cervical magnetic 489 
stimulation have been utilized for the identification of diaphragm weakness. Pressures below 490 
20 cmH2O for bilateral phrenic nerve stimulation (such as that performed in this study) are 491 
potentially indicative of bilateral diaphragm weakness (ATS/ERS Taskforce, 2002). 492 
Pressures below 18 cmH2O correlate with observations of muscle weakness in some diseases 493 
(Steier et al., 2007), while those below 10 cmH2O in critically ill patients indicate acquired 494 
diaphragm weakness (Supinski and Callahan, 2013). Recently, Dubé and Dres (2016) 495 
produced algorithms for the suspicion and treatment of diaphragm dysfunction and proposed 496 
a twitch Pdi < 20 cmH2O (or < 10 cmH2O for unilateral phrenic nerve stimulation) is 497 
indicative of bilateral diaphragm weakness. However, as these cut-off values are based on 498 
respiratory pressures measured using balloon catheters, which based on our findings record 499 
lower Pdi. For example, the mean Pdi twitch pressure for patients with severe stable COPD, 500 
measured using balloon catheters by Polkey et al., is 18.5 cmH2O (1996). If a micro-501 
transducer catheter was used, and the twitch Pdi bias from our Experiment 2 (~6.9 cmH2O 502 
higher) factored in, the recorded value would have been closer to ~25.4 cmH2O indicating 503 
that diaphragm weakness is instead unlikely. Thus, applying the aforementioned cut-off 504 
values measured using balloon catheters to those measured using a micro-transducer catheter 505 
may lead to incorrect clinical assessments and diagnoses. This should therefore be considered 506 
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if micro-transducer catheters are used in the evaluation of diaphragm weakness, and it may be 507 
necessary to establish new normative and cut-off values.  508 
Alternatively, our results have demonstrated that a surrogate measurement for direct 509 
comparisons between micro-transducer and balloon catheters may be pressure area, which 510 
corrects for differences in the pressure response shape between the catheters. If normative 511 
values and cut-off values for pressure areas were ascertained, then these measurements would 512 
allow for comparisons between the catheters to be made. Given the presence of a main effect 513 
of catheter on Pdi, and the significant differences observed between catheters at 100% 514 
stimulation power, we would also expect significant differences between catheters when 515 
measuring potentiated twitch Pdi (e.g. twitches delivered after a maximal volitional 516 
inspiratory maneuver). Thus, between catheter comparisons of diaphragm contractility test 517 
results should be interpreted with care. Response and relaxation rates (e.g., muscle shortening 518 
and relaxation rates) following cervical magnetic stimulation also provide valuable 519 
information pertaining to the mechanical properties of the the diaphragm (ATS/ERS 520 
Taskforce, 2002, Laveneziana et al., 2019, Wilcox et al., 1988). The present study shows, 521 
however, that response and relaxation rates differ between the micro-transducer and balloon 522 
catheters. Therefore, caution is warranted when comparing studies that have used different 523 
catheter systems to obtain these measurements.  524 
 525 
CONCLUSION 526 
This is the first study to provide a comparative analysis of the pressure measurement 527 
characteristics of micro-transducer and balloon catheters in response to controlled 528 
pressurizations in vitro (Experiment 1) and cervical magnetic stimulations in vivo 529 
(Experiment 2). Under in vivo and in vitro conditions, the micro-transducer catheter recorded 530 
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higher pressure amplitudes, and under in vivo conditions, shorter response and relaxation 531 
rates and greater rates of changes in pressure compared to the balloon catheters. Accordingly, 532 
caution is warranted when comparing the results of studies that used different catheter 533 
systems to obtain these measurements. Furthermore, in a clinical setting caution is warranted 534 
if pressure amplitude measurements made with micro-transducer catheters are compared to 535 
normative values derived from balloon catheters. However, this limitation may be mitigated 536 
if comparisons are made based on pressure area, which does not differ between micro-537 
transducer and balloon catheters.  538 
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Table 1. Experiment 1 – in vitro: Measurement characteristics and agreement for pressure amplitudes and areas between the balloon catheter 690 
(BC) and micro-transducer catheter (MC) at increasing chamber pressures of 25, 50, 75 and 100 cmH2O with a constant pressurization time of 691 
0.2 s. Bias values were calculated as catheter pressure subtracted from reference pressure. Values are mean ± SD calculated from 100 responses 692 
to each chamber pressure. 693 
Abbreviations: RP, reference pressure; LOA, limits of agreement (bias ± 1.96 SD).  694 
 25 cmH2O 50 cmH2O 75 cmH2O 100 cmH2O 
 BC MC BC MC BC MC BC MC 
Amplitude (cmH2O) 22.8 ± 0.1 24.7 ± 0.1 44.9 ± 0.1 47.7 ± 0.1 66.2 ± 0.1 69.3 ± 0.1 84.8 ± 0.1 89.7 ± 0.1 
Amplitude (%RP) 91 ± 0 99 ± 0 90 ± 0 95 ± 0 89 ± 0 93 ± 0 86 ± 0 90 ± 0 
Amplitude Bias (cmH2O) 2.2 0.4 5.0 2.3 8.6 5.5 14.4 9.6 
Amplitude LOA (cmH2O) 2.2 to 2.3 0.3 to 0.5 5.0 to 5.1 2.2 to 2.4 8.5 to 8.7 5.4 to 5.6 13.8 to 15.0 8.9 to 10.2 
Area (cmH2O·s) 4.17 ± 0.02 4.39 ± 0.02 8.59 ± 0.02 8.83 ± 0.02 13.2 ± 0.03 13.4 ± 0.03 17.8 ± 0.03 18.0 ± 0.04 
Area (%RP) 97 ± 0 102 ± 0 98 ± 0 101 ± 0 98 ± 0 99 ± 0 97 ± 0 98 ± 0 
Area Bias (cmH2O·s) 0.12 -0.10 0.17 -0.08 0.24 0.08 -0.51 -0.36 
Area LOA (cmH2O·s) 0.11 to 0.13 -0.12 to -0.08 0.16 to 0.18 -0.11 to -0.05 0.22 to 0.26 0.04 to 0.11 -0.52 to -0.49 -0.39 to -0.33 
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 Pes Pga Pdi 
 BC MC BC MC BC MC 
Amplitude (cmH2O) 15.8 ± 4.1* 20.5 ± 6.4 9.0 ± 3.1* 13.1 ± 4.2 24.2 ± 5.0* 32.1 ± 8.3 
Amplitude (%max) 89 ± 9 87 ± 12 78 ± 16 74 ± 19 94 ± 4 92 ± 5 
Area (cmH2O·s) 2.4 ± 0.7 2.3 ± 0.7 2.9 ± 1.3 2.5 ± 1.6 4.5 ± 0.9 4.3 ± 1.2 
10-90% Rise time (ms) 66 ± 9* 43 ± 8 78 ± 21* 38 ± 18 69 ± 8* 47 ± 8 
Time to peak pressure (ms) 97 ± 13* 66 ± 12 121 ± 36* 58 ± 28 146 ± 13* 95 ± 12 
Latency (ms) 49 ± 5* 33 ± 6 39 ± 3* 27 ± 7 42 ± 3* 27 ± 3 
Half-relaxation (ms) 89 ± 12* 60 ± 12 132 ± 67* 82 ± 58 108 ± 14* 70 ± 7 
Time constant (ms) 70 ± 30 54 ± 24 197 ± 182 125 ± 135 106 ± 13 98 ± 39 
MRPD (%gain/10ms) 12.8 ± 2.1* 18.4 ± 1.7 13.6 ± 2.3* 18.7 ± 2.9 12.6 ± 1.4* 17.3 ± 1.8 
MRR (%loss/10ms) 8.1 ± 2.3* 10.4 ± 2.5 5.9 ± 3.2* 8.2 ± 3.2  5.6 ± 0.7* 8.9 ± 2.0 
Pressure at end-expiration (cmH2O) -1.4 ± 2.1 0.8 ± 2.5 13.5 ± 5.1* 10.6 ± 2.2 16.0 ± 3.5* 9.7 ± 3.0 
 695 
Table 2. Experiment 2 – in vivo: Esophageal pressure (Pes), gastric pressure (Pga) and transdiaphragmatic pressure (Pdi) measurement 696 
characteristics for balloon catheters (BC) and micro-transducer catheter (MC) following cervical magnetic stimulation at 100% of stimulator 697 
power output. Data are mean ± SD and pooled from visits 1 and 2.  698 
Abbreviations: MRPD, maximum rate of pressure development; MRR, maximum rate of relaxation. Significantly different from micro-699 
transducer catheter (*P < 0.05). 700 
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 Pes Pga Pdi 
 BC MC BC MC BC MC 
Within-day (CV) 
Amplitude (%) 8.7 (5.2 to 12.3) 10.7 (6.4 to 14.9) 6.7 (4.1 to 9.2) 12.9 (8.3 to 17.5) 6.2 (3.0 to 9.4) 6.1 (4.0 to 8.3) 
Area (%) 14.5 (9.3 to 19.6) 12.8 (8.2 to 17.4) 14.9 (7.1 to 22.8) 23.4 (12.1 to 34.6) 9.6 (5.3 to 14.0) 8.6 (4.6 to 12.6) 
Between-day (CV) 
Amplitude (%) 10.7 (8.1 to 13.3) 10.9 (7.8 to 14.0) 20.7 (17.5 to 23.9) 17.8 (11.1 to 24.4) 9.8 (6.0 to 13.6) 11.3 (5.3 to 17.2) 
Area (%) 15.0 (12.1 to 18.0) 16.0 (12.4 to 19.7) 30.6 (17.9 to 43.3) 26.4 (21.1 to 31.8) 13.0 (9.0 to 17.0) 18.5 (7.8 to 29.2) 
Between-day (ICC) 
Amplitude  0. 93 (0.69 to 0.99) 0.934 (0.70 to 0.99) 0.72 (-0.58 to 0.95) 0.60 (-1.54 to 0.92) 0.81 (-0.05 to 0.96) 0.82 (0.08 to 0.96) 
Area  0. 94 (0.71 to 0.99) 0.903 (0.56 to 0.98) 0.68 (-0.92 to 0.93) 0.60 (-0.87 to 0.92) 0.79 (-0.12 to 0.96) 0.58 (-1.37 to 0.92) 
 702 
Table 3. Experiment 2 – in vivo: Within- and between day reliability of esophageal pressure (Pes), gastric pressure (Pga) and transdiaphragmatic 703 
pressure (Pdi) amplitudes and areas for balloon catheters (BC) and micro-transducer catheter (MC) following cervical magnetic stimulation at 704 
100% of stimulator power output. Data are presented as means with 95% confidence intervals in parentheses.  705 
Abbreviations: CV, coefficient of variation; ICC, intraclass correlation coefficient. 706 
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FIGURE LEGENDS 708 
Figure 1. Pressure response analysis. A, stimulation event; B, pressure 5% above baseline; A-B, latency; C-E, 10-90% rise time; D, point of the 709 
maximal rate of pressure development calculated as derivative at D divided by pressure amplitude at F; G, point of the maximal relaxation rate 710 
calculated as derivative at G divided by pressure amplitude at F; F, peak pressure; A-F, time to peak pressure; B-F, contraction time; F-I, half-711 
relaxation time; H-J, time constant calculated from 60-5% pressure amplitude. 712 
 713 
Figure 2. Experiment 1 – in vitro: Ensemble average waveforms (each from 100 waves) from the micro-transducer catheter (MC), balloon 714 
catheter (BC) and reference (RP) pressures in response to chamber pressures of 25, 50, 75 and 100 cmH2O with a constant pressurization time of 715 
0.2 s.  716 
 717 
Figure 3. Experiment 2 – in vivo: Representative esophageal, gastric and transdiaphragmatic pressure characteristics for the balloon catheters and 718 
micro-transducer catheter following cervical magnetic stimulation at 100% of stimulator power output. Three repeated twitches from one 719 
participant are shown superimposed. Stimulation artefacts are marked with an arrow (↑). 720 
 721 
Figure 4. Experiment 2 – in vivo: Esophageal, gastric and transdiaphragmatic pressure amplitudes (top panels) and areas (bottom panels) for 722 
balloon catheters and micro-transducer catheter following cervical magnetic stimulation at increasing stimulation intensities. Data are mean  723 
SD and pooled from visits 1 and 2. Significant difference between catheters (*P < 0.05; **P < 0.01). 724 
 725 
Figure 5. Experiment 2 – in vivo: Bland-Altman plots of esophageal, gastric and transdiaphragmatic pressure amplitudes (top panels) and areas 726 
(bottom panels) between balloon catheters (BC) and micro-transducer catheter (MC) following cervical magnetic stimulation at increasing 727 
stimulation intensities. Bias is represented by the solid line and the limits of agreement by the dotted lines (± 1.96 SD). Each participant has one 728 
datapoint per stimulation power and each datapoint was calculated as the mean value from visits 1 and 2. 729 
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